Skip to main content
    B

    Bioceres Crop Solutions Corp (BIOX)

    Official site

    BASIC MATERIALS • AGRICULTURAL INPUTS • NASDAQ

    $0.20
    -0.01 (-4.90%)

    Market Cap: $13.40M

    Last updated: Nov 17, 2026 at 10:59 AM ET

    Bioceres Crop Solutions Corp (BIOX) Financials: Revenue, Profit and Cash Flow

    Updated Sep 14, 2026. Financial statements from company filings, amounts in US dollars.

    Bioceres Crop Solutions reported revenue of $237.80M for the fiscal year ended Jun 30, 2026, down 28.7% from the year before. That year, net income was -$230.30M with a net margin of -96.8%, operating cash flow was $52.60M and free cash flow was $51.55M. The quarter ended Jun 30, 2026 had revenue of $57.00M and net income of -$27.50M.

    Revenue and Margins

    The operating margin was 0.0% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from $93.71M, a compound annual rate of 10.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Jun 2026$237.80M-28.7%34.7%0.0%-96.8%
    Jun 2025$333.34M-28.3%38.4%-0.2%-16.6%
    Jun 2024$464.83M+10.8%39.1%9.6%0.7%
    Jun 2023$419.45M-99.9%43.9%12.6%4.5%
    Jun 2022$328.46B+158806.3%36.6%11.8%-2.2%
    Jun 2021$206.70M+19.9%44.0%18.6%-3.3%
    Jun 2020$172.35M+7.5%46.1%22.7%1.9%
    Jun 2019$160.31M+20.1%45.9%20.0%-11.5%
    Jun 2018$133.49M+42.5%42.2%11.8%-8.3%
    Jun 2017$93.71MN/A36.1%-0.8%-12.6%
    Annual, fiscal years ended Jun 2017 to Jun 2026

    Income Statement

    In the fiscal year ended Jun 2026, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Revenue$237.80M$333.34M$464.83M$419.45M$328.46B$206.70M$172.35M$160.31M$133.49M$93.71M
    Cost of revenue$155.40M$205.19M$283.24M$235.46M$208.36B$115.82M$92.86M$86.68M$77.09M$59.86M
    Gross profit$82.40M$128.15M$181.59M$183.99M$120.09B$90.88M$79.49M$73.62M$56.40M$33.85M
    Research and development$11.03M$14.91M$17.18M$15.35M$6.95B$5.62M$4.20M$3.69M$3.95M$3.98M
    Operating income$100.00K-$761.90K$44.82M$52.99M$38.73B$38.38M$39.15M$32.09M$15.71M-$706.92K
    Net income-$230.30M-$55.42M$3.24M$18.78M-$7.20B-$6.87M$3.36M-$18.37M-$11.04M-$11.82M
    EBITDA$100.00KN/A$55.46M$62.28M$39.88B$43.70MN/AN/AN/A$3.90M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$57.00M$38.20M$73.67M$77.44M$74.40M$59.60M$98.88M$92.62M$124.31M$84.00M$140.30M$116.18M
    Gross profit$13.80M$11.50M$26.31M$35.64M$24.20M$23.47M$41.32M$37.24M$46.07M$42.60M$51.50M$43.53M
    Operating income-$10.10M-$6.50M$7.82M$7.76M-$14.90M$933.21K$15.19M$3.66M$9.48M$13.20M$16.80M$5.29M
    Net income-$27.50M-$12.30M-$183.04M-$7.33M-$44.30M-$1.30M$143.53K-$6.37M-$1.53M$9.26M$108.45K-$4.59M
    Last 12 quarters

    Balance Sheet

    As of Jun 2026, total debt of $227.98M exceeded cash and equivalents by $216.78M.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Total assets$471.30M$763.65M$852.55M$818.06M$518.22M$394.59M$297.56M$242.47M$196.64M$239.87M
    Current assets$215.20M$308.31M$408.67M$397.11M$297.71M$211.49M$164.69M$98.21M$85.34M$87.77M
    Cash and equivalents$11.20M$32.70M$44.47M$48.13M$33.48M$36.05M$27.16M$3.45M$2.22M$1.68M
    Total liabilities$407.20M$468.43M$501.17M$487.56M$359.92M$304.30M$237.51M$180.37M$163.51M$160.13M
    Short-term debt$168.00M$228.88M$139.87M$111.50M$72.71M$77.54M$64.39M$66.48M$65.31M$34.04M
    Long-term debt$59.98M$38.20M$122.91M$135.88M$135.90M$86.74M$96.65M$84.26M$25.71M$40.95M
    Shareholder equity$39.10M$262.81M$315.30M$298.85M$127.61M$67.74M$45.48M$47.30M$33.13M$38.34M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$471.30M$529.60M$560.36M$734.88M$763.65M$798.21M$835.20M$827.26M$850.63M$836.13M$817.20M$819.70M
    Total liabilities$407.20M$439.70M$453.75M$455.83M$468.43M$453.24M$488.87M$481.23M$501.06M$487.60M$482.00M$496.36M
    Cash and equivalents$11.20M$14.40M$11.06M$15.51M$32.70M$38.46M$29.18M$32.28M$44.47M$16.36M$24.40M$28.37M
    Shareholder equity$39.10M$63.80M$73.77M$249.38M$262.81M$308.71M$309.81M$309.74M$314.01M$313.35M$300.50M$289.68M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Jun 2026, free cash flow was 98.0% of operating cash flow.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Operating cash flow$52.60M$49.91M$41.72M$2.59M-$17.52M-$6.21M$9.32M$29.69M$18.39M$19.10M
    Capital expenditures$1.05M$14.61M$22.78M$22.56M$9.00M$13.92M$4.50M$3.45M$5.71M$1.39M
    Free cash flow$51.55M$35.30M$18.93M-$19.97M-$26.51M-$20.13M$4.82M$26.25M$12.68M$17.71M
    Dividends paid$0$0$0$0$0$1.03M$0$0$0$0
    Investing cash flow-$5.86M-$6.13M-$28.73M-$25.73M$2.90M-$8.31M-$7.80M-$3.26M-$8.22M-$20.16M
    Financing cash flow-$65.30M-$50.71M-$10.06M$32.95M$14.82M$7.36M$33.53M-$26.95M-$10.46M$2.33M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flowN/AN/A$17.39M$14.38M$26.77M$23.34M-$5.36M$5.16M$23.26M-$17.39M$21.12M$14.73M
    Capital expenditures$0$0$216.11K$1.37M$2.18M$5.91M$3.38M$3.14M$2.02M$5.98M$4.75M$6.00M
    Free cash flowN/AN/A$17.17M$13.01M$24.59M$17.43M-$8.73M$2.02M$21.24M-$23.37M$16.37M$8.74M
    Last 12 quarters

    Frequently Asked Questions About BIOX

    What is Bioceres Crop Solutions' annual revenue?

    Bioceres Crop Solutions reported revenue of $237.80M for the fiscal year ended Jun 30, 2026.

    How fast is Bioceres Crop Solutions' revenue growing?

    Revenue was down 28.7% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -17.2%.

    Is Bioceres Crop Solutions profitable?

    No. Bioceres Crop Solutions reported net income of -$230.30M for the fiscal year ended Jun 30, 2026, with a net margin of -96.8%.

    How much free cash flow does BIOX generate?

    For the fiscal year ended Jun 30, 2026, operating cash flow of $52.60M minus capital expenditures of $1.05M produced free cash flow of $51.55M.

    How much debt does Bioceres Crop Solutions have?

    The balance sheet dated Jun 30, 2026 reported long-term debt of $59.98M, short-term debt of $168.00M and cash and equivalents of $11.20M.